Torcetrapib: when global risk reduction goes 'off target'.
Jackson
G
G
D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use; D040242:Risk Reduction Behavior
D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D011804:Quinolines; C483909:torcetrapib